3 TSX Stocks That Can Double in the Next Six Months

Growth investors can look to buy TSX stocks such as HEXO and Cronos to beat the index and derive outsized gains in 2021.

| More on:
funds, money, nest egg

Image source: Getty Images

Investors looking to buy stocks often aim to beat the broader markets on a consistent basis. The best way to achieve this goal is to add quality growth stocks to your portfolio. You need to identify companies that are part of rapidly expanding markets allowing them to increase the top-line and profit margins at a stellar pace over time.

Here, we look at three such stocks with the potential to deliver outsized gains to investors in the second half of 2021.

HEXO

The first stock on my list is Canadian marijuana heavyweight HEXO (TSX:HEXO)(NYSE:HEXO), a company that has gone on an acquisition spree this year. In May, HEXO announced it would acquire Redecan for a whopping $925 million in a cash and stock deal.

This transaction may propel HEXO to the number one position in Canada’s recreational cannabis segment as the combined entity will have a market share of 17% in the country’s adult-use market. Currently, Tilray is Canada’s largest recreational cannabis company with a market share of 15.5%.

Prior to the acquisition of Redecan, HEXO already led the recreational cannabis market in Montreal as well as the cannabis-infused beverage segment. Redecan will be highly accretive for HEXO as the former increased sales by 169% in Q1 with gross margins north of 50%.

Score Media and Gaming

Score Media and Gaming (TSXV:SCR)(NASDAQ:SCR) is a sports media company. It provides users with theScore, which is a mobile sports application where you can access customizable news as well as scores and stats for multiple leagues and sports. Its other major business segment is theScore Bet, a mobile sports betting platform that delivers pre-game and in-game betting options, real-time scores as well as in-game data.

Score Media and Gaming increased its sales from $27.7 million in fiscal 2018 (ended in August) to $31.1 million in fiscal 2019. However, as sporting events were postponed amid COVID-19, its sales fell to $20.7 million in 2020.

Now, betting legalization is gaining pace in Canada and several states in the U.S., thereby unlocking several growth opportunities for SCR. Analysts expect the company’s sales to rise by 59% to $33 million in 2021 and by a monstrous 105% to $67.5 million in 2022.

Analysts tracking the stock have a price target of $45 for SCR, which is 100% above its current trading price.

Cronos Group

The final stock on my list is Cronos Group (TSX:CRON)(NASDAQ:CRON) that is down 68% from record highs. In Q1 of 2021, Cronos Group reported sales of $12.6 million which was a growth of 50% year over year. However, its net loss stood at $161.6 million or $0.44 per share in Q1 compared to earnings of $75.7 million or $0.20 per share in the year-ago period. Its EBITDA loss of $37.1 million was similar to the prior year’s quarter.

Cronos is forecast to increase its sales by 55% to $72.26 million in 2021 and by 84% to $133 million in 2022. The company is backed by tobacco giant Altria which provides it with financial flexibility and leeway to improve its bottom line in the upcoming quarters.

In case cannabis is legalized at the federal level in the U.S., investors can expect Cronos stock to touch all-time highs and gain significant momentum in the near term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »

Marijuana plant and cannabis oil bottles isolated
Cannabis Stocks

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030

Quality cannabis stocks such as Green Thumb and Cresco Labs are positioned to deliver outsized gains to shareholders in 2024…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

The Big Mistake I See Cannabis Investors Making Over and Over Again

The news of marijuana slated to be legalized next year has seen a boost for cannabis investors, but they must…

Read more »